While CDK 4/6 are the most studied members of the CDK family in relation to endocrine-resistant breast cancer, our analysis revealed another member of this family, CDK1 to be important for both endocrine resistance and TNBC. The gene discussed is CDK1; the disease is breast carcinoma.